Minimal residual disease in peripheral blood stem cell harvests from high-risk neuroblastoma patients.

Abstract

PURPOSE We investigated whether detection of minimal residual disease (MRD) in peripheral blood stem cells (PBSC) by using tyrosine hydroxylase (TH) expression could predict outcome of patients with advanced neuroblastoma. PATIENTS AND METHODS Quantitative real time polymerase chain reaction was performed for the detection of tumor contamination using TH… (More)
DOI: 10.1097/MPH.0b013e31818e532c

Topics

3 Figures and Tables

Cite this paper

@article{Avigad2009MinimalRD, title={Minimal residual disease in peripheral blood stem cell harvests from high-risk neuroblastoma patients.}, author={Smadar Avigad and Galina Feinberg-Gorenshtein and D. S. M. Luria and Marta Jeison and Jerry Stein and Anna Grunshpan and Yacov Sverdlov and Shifra Ash and Isaac Yaniv}, journal={Journal of pediatric hematology/oncology}, year={2009}, volume={31 1}, pages={22-6} }